Zika virus NS1 suppresses the innate immune responses via miR-146a in human microglial cells

Area of Science:

• Virology
• Neuroimmunology
• Molecular Biology

Background:

• Zika virus (ZIKV) infection is linked to congenital ZIKV syndrome and Guillain-Barré Syndrome.
• ZIKV non-structural protein 1 (sNS1) is crucial for viral replication and immune evasion.
• Microglial cells are key players in central nervous system (CNS) immune responses.

Purpose of the Study:

• To investigate the immunomodulatory effects of ZIKV-NS1 on human microglial cells.
• To elucidate the role of microRNA-146a (miR-146a) in mediating the bystander effects of ZIKV-NS1.

Main Methods:

• Real-Time PCR and Immunoblotting were used to analyze gene and protein expression.
• Overexpression and knockdown studies were performed to assess functional impacts.
• Reactive oxygen species (ROS) production was measured to evaluate cellular stress responses.

Main Results:

• ZIKV-NS1 significantly induced miR-146a expression in human microglial cells.
• Upregulated miR-146a led to decreased expression of TRAF6 and STAT-1.
• This resulted in the suppression of downstream inflammatory pathways, including pNF-κBp65 and TNF-α, and reduced ROS activity.

Conclusions:

• ZIKV-NS1 exerts a bystander effect by suppressing pro-inflammatory and cellular antiviral responses in microglial cells.
• The miR-146a pathway is a key mechanism through which ZIKV-NS1 modulates microglial immune activity.
• These findings offer insights into ZIKV pathogenesis and potential therapeutic targets.